Breast Cancer | Tumor

CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.

Friday Frontline: A Two-Time Cancer Survivor Becomes the Oldest Living American, A Nurse Serves as a Surrogate for a Cancer Survivor, And More

May 7th 2021

From a 114-year-old cancer survivor breaking records to an operating room nurse giving birth to a cancer survivor’s baby, here’s what’s happening in the cancer landscape this week.

FDA Committee Recommends Continuing Accelerated Approval Status of Tecentriq in Certain Patients with Metastatic Triple-Negative Breast Cancer

May 6th 2021

Members of an FDA committee voted in favor of Tecentriq plus Abraxane keeping its accelerated approval for the treatment of adults with unresectable, locally advanced or metastatic triple-negative breast cancer whose tumors express PD-L1.

Unhealthy Habits May Increase in Some Women After a Breast Cancer Diagnosis

May 5th 2021

Women who receive a breast cancer diagnosis were more likely to develop unhealthy behaviors one and two years after diagnosis, even if they were considered healthy at time of diagnosis.

Advances in Second Opinions For Cancer Treatment Decisions

April 27th 2021

Second opinions may enhance your treatment plan or even change your course.

Real Burden of Cancer ‘Won’t Go Away’ Because of COVID-19

April 20th 2021

After the COVID-19 pandemic caused a delay in cancer screenings, an expert from Karmanos Cancer Hospital and Network urges patients to resume their routine preventative care to avoid any delay in a possible diagnosis.

Highlights From CURE®'s Educated Patient® Breast Cancer Summit

April 8th 2021

If you missed any part of CURE®’s Educated Patient® Breast Cancer Summit, take a look at this roundup of stories that highlight the expert insight and guidance that was shared throughout the day.

FDA Grants Regular Approval to Trodelvy for Certain Patients With Triple-Negative Breast Cancer

April 7th 2021

Approximately one year after granting Trodelvy accelerated approval, the Food and Drug Administration granted a regular approval to the antibody-drug conjugate in certain patients with pretreated triple-negative breast cancer.

Endocrine Therapies May Lower Estradiol Levels in Men With Breast Cancer

April 7th 2021

Men with breast cancer who were treated with Soltamox plus gonadotropin-releasing hormone analogue had a decrease in estradiol levels of 85%, whereas Aromasin plus gonadotropin-releasing hormone analogue reduced these levels by 72%.

FDA Committee Votes to Delay Approval Decision on Keytruda in Early TNBC Until More Data is Available

April 4th 2021

The Food and Drug Administration’s Oncologic Drugs Advisory Committee unanimously voted in favor of waiting for more data before making an approval decision involving the use of Keytruda in early triple-negative breast cancer.

Off Our Chests: An Oncologist Turned Caregiver and His Wife Share Their Cancer Journey From All Angles

April 1st 2021

Dr. John Marshall and his wife, Liza, look back on the trials and tribulations of Liza’s triple-negative breast cancer diagnosis – from the perspective of a patient and her husband, the caregiver and oncologist.

Treating HER2+ Metastatic Breast Cancer During the COVID-19 Pandemic

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, and Sara A. Hurvitz, M.D., discuss treatment approaches and modifications during the COVID-19 pandemic.

Adhering to Oral Therapy for HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses the learning curve of taking an oral medication, tucatinib, in combination with chemotherapy, and Sara A. Hurvitz, M.D., reviews methods for medication adherence.

Tucatinib With Chemotherapy for HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses how her quality of life has been since she began taking tucatinib with chemotherapy.

Advances in HER2+ Metastatic Breast Cancer

March 30th 2021

Sara A. Hurvitz, M.D., reviews the advances in HER2+ metastatic breast cancer that have been made over the past decade.

Goals of Treatment After Progression of HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her goals of treatment after progression of disease.

Progression of HER2+ Metastatic Breast Cancer

March 30th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares the hope she had after progression because of the ongoing research for HER2+ breast cancer, and Sara A. Hurvitz, M.D., reviews the drug regimens available in this realm.

Keytruda May Not Improve Overall Survival Versus Chemotherapy in Metastatic Triple-Negative Breast Cancer

March 26th 2021

Although Keytruda did not improve overall survival when compared with chemotherapy, patients with a higher PD-L1 expression may derive a greater benefit with Keytruda, as shown with a longer median overall survival.

Friday Frontline: Baltimore Restaurant Owner Drives Six Hours to Cook for Customer with Terminal Cancer, Breast Cancer Treatment Pioneer José Baselga Dies from Rare Degenerative Disorder, and More

March 26th 2021

From a Baltimore restaurant owner traveling six hours to cook for a terminally ill customer to the death of a pioneer in breast cancer treatment, here’s what’s happening in the cancer landscape this week.

Younger Age and Non-White Race Associated With an Increased Likelihood of Filing for Bankruptcy After a Breast Cancer Diagnosis

March 23rd 2021

Data from a recent study demonstrates that patients with breast cancer — especially those who are younger, privately insured, of non-White race and lower-income — are more likely to file for bankruptcy than those without cancer.

Is Delaying Cancer Screening Due to COVID-19 Fears Worth the Risk?

March 18th 2021

Postponing tests or doctor visits during the pandemic may increase women’s risk of cancer.

Understanding Survivor’s Guilt

March 18th 2021

Why do some survive cancer, while others don’t? And why do those who survive often feel the aches of survivor’s guilt? Here, a survivor shares how she learned to cope.

Diet and Exercise Can Play an Important Role in Breast Cancer Survivors

March 17th 2021

Increasing healthy eating habits and exercise is important in patients with breast cancer, according to an expert from Mass General Cancer Center.

Understanding HER2+ Metastatic Breast Cancer

March 16th 2021

Sara A. Hurvitz, M.D., reviews the history of HER2+ breast cancer and the progressive research that has been done in this disease.

Understanding Treatment Options for HER2+ Metastatic Breast Cancer

March 16th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, describes her experience learning about the surplus of treatment options and how she overcame her initial apprehension.

Being Diagnosed With HER2+ Metastatic Breast Cancer

March 16th 2021

Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her initial impression of when she was diagnosed.

Classifying Breast Cancer

March 16th 2021

Sara A. Hurvitz, M.D., describes the subtypes, staging and grading of breast cancer.

‘Flat’ Women are Reshaping the Fashion World

March 13th 2021

Body image and body positivity are very important, especially after a life-changing surgery such as a mastectomy, writes a breast cancer survivor. Here, she offers fashion suggestions for “flatties” to feel their best.

‘The Future is Brighter’ for Triple-Negative Breast Cancer

March 11th 2021

Triple-negative breast cancer, which is found in 15%-20% of invasive breast cancers, is a challenge when it comes to treatment, but thanks to new drug approvals and therapy regimens, the treatment landscape has progressed in recent years, according to an expert.

How Targeted Therapies Are Changing the Breast Cancer Treatment Landscape

March 11th 2021

Targeted therapies that attack cancer in a more precise way than traditional chemotherapy are being used more often in the field of breast cancer, but the solution in utilizing them lies within the patient-oncologist relationship, according to an expert from the Massachusetts General Hospital Cancer Center.

How Patients With Cancer Can Boost Their ‘Mindfulness Muscle’ and Improve Resiliency

March 10th 2021

Mindfulness practices have been associated with improved mental health outcomes in patients with cancer. Here, an expert shares tips on how patients can strengthen their “mindfulness muscle.”

NEXT PAGE
PREVIOUS PAGE